UPDATE – Johnson & Johnson COVID-19 vaccine news

As of April 13, 2021, the FDA and CDC are recommending a pause in the use of the Johnson & Johnson (Janssen) COVID-19 vaccine due to a very rare and severe blood clot in some individuals who received it. Safety is a top priority for the CDC, and the use of this vaccine is on hold until these cases and analysis can be further reviewed and assessed later this week. Review this update for more information and how claims will be handled during this time.

COVID-19 billing and temporary provision updates

The COVID-19 Billing Guide and Summary of COVID-19 Temporary Program Provisions are handy references to current program and billing information.